Article d’analyse • Jun 18

Genworth Financial (GNW) Stock Looks Rich After CareScout Launch And Enact Strength

Genworth Financial (GNW) has reshaped its long term care footprint by ending new LTC insurance sales through its legacy unit and launching CareScout Insurance, which offers a new product available in 40 states. See our latest analysis for Genworth Financial. Against this backdrop of reshaping its long term care offerings, Genworth Financial’s share price at $8.97 reflects modest recent moves, with a 90 day share price return of 12.41% and a 1 year total shareholder return of 15.30%. The 3 and...

Seeking Alpha • Jun 08

Enact Holdings Continues To Be The Driver For Genworth Financial

Summary Genworth Financial is maintained as a Buy, but with increased caution due to persistent challenges outside its Enact Holdings stake. GNW's valuation remains heavily discounted relative to its $4.7B ACT stake, while legacy long-term care and closed-block businesses continue to drag earnings. Shareholder value is driven by aggressive buybacks, with FY 2026 repurchases guided to $195–$225M and a potential $750M legal windfall pending appeal. Key risks include adverse housing market trends impacting ACT and uncertainty around the AXA legal case; CareScout expansion offers long-term optionality. Read the full article on Seeking Alpha

Article d’analyse • Jul 04

Genworth Financial, Inc.'s (NYSE:GNW) Price Is Right But Growth Is Lacking

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...

Seeking Alpha • Feb 27

Genworth Continues Gradual Progress, But Enact Is Under Pressure

Summary Genworth Financial is undergoing a multi-year turnaround, focusing on improving its long-term care and life insurance business segments. Despite recent earnings disappointments, I remain optimistic about Genworth's long-term prospects, though the turnaround may take longer than initially expected. I have downgraded GNW from Strong Buy to Buy due to concerns about Enact Holdings, which faces challenges from a weakening housing market. Read the full article on Seeking Alpha

Article d’analyse • Feb 24

Investors Don't See Light At End Of Genworth Financial, Inc.'s (NYSE:GNW) Tunnel

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...

Seeking Alpha • Oct 08

A Failed Merger May Have Been Just What Genworth Financial Needed For A Turnaround

Summary After seeing its stock price get cut in half over the last decade, Genworth Financial appears to be poised for a significant turnaround. The company's 80% ownership of Enact should make GNW trade just above $10 per share assuming no value in its insurance and annuity segments. There really is no other company that combines mortgage insurance, life insurance, and long-term care, which makes any peer comparison imperfect. Nonetheless, GNW appears to be undervalued by most metrics. Read the full article on Seeking Alpha

Article d’analyse • Oct 05

Genworth Financial, Inc.'s (NYSE:GNW) Price Is Right But Growth Is Lacking

When close to half the companies operating in the Insurance industry in the United States have price-to-sales ratios...

Article d’analyse • May 23

Investors Aren't Buying Genworth Financial, Inc.'s (NYSE:GNW) Revenues

Genworth Financial, Inc.'s ( NYSE:GNW ) price-to-sales (or "P/S") ratio of 0.4x may look like a pretty appealing...

Article d’analyse • Jan 17

There Is A Reason Genworth Financial, Inc.'s (NYSE:GNW) Price Is Undemanding

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 17x, you may...

Seeking Alpha • Nov 21

Genworth's Sum Of The Parts May Be Greater Than The Whole

Summary Genworth Financial shares have performed well over the past year, despite the company's struggles in the long-term care insurance business. The company's structure protects it from having to inject capital into the struggling long-term care entity, which may eventually go bankrupt. Genworth's stake in Enact is worth more than the company's current market value, providing potential upside for investors. Read the full article on Seeking Alpha

Seeking Alpha • Aug 08

Genworth Financial: Valuation Update

Summary Genworth reports Q2 earnings this week. Heading into earnings, the company is fairly valued at $6.24/sh. Shareholders would benefit from a more aggressive reduction in the company's debt. Things to watch for in the report are progress on MYRAP, CareScout updates, and AXA litigation. Overall, Genworth receives a Hold recommendation. Read the full article on Seeking Alpha

Seeking Alpha • Jun 20

Genworth Financial: Beaten Down Valuation Makes It A Buy

Summary Genworth Financial's stake in Enact Holdings is worth over $3 billion, making the company undervalued with a market cap of around $2.4 billion. The company has improved its balance sheet, reduced debt, and built a solid investment portfolio, supporting the investment case at current price levels. Risks include losses in the long-term care insurance segment and potential impact on financial strength ratings. Read the full article on Seeking Alpha

Seeking Alpha • Feb 05

Genworth Financial Q4 2022 Earnings Preview

Genworth Financial (NYSE:GNW) is scheduled to announce Q4 earnings results on Friday, February 3rd, after market close. The consensus EPS Estimate is $0.23 Over the last 2 years, GNW has beaten EPS estimates 100% of the time and has beaten revenue estimates 75% of the time.

Seeking Alpha • Jan 03

Genworth Financial: The Bulls Overwhelm The Bears - Running At Full Speed

Summary Genworth Financial has had high income growth over the past 5 years. Genworth Financial shows rising free cash flow. Genworth Financial also has increasing EPS. Genworth Financial is in a market with potential. Genworth Financial, Inc. (GNW) provides insurance and annuity products in the U.S. Internationally, the company's main focus is on life, mortgage, and long-term-care insurance. Genworth Financial stock has been trending up as we closed the year, while the S&P 500 Index (SP500) has continued to trend south. Let's take a closer look at Genworth Financial and why I believe it will be an outperformer for 2023. We'll start with an analysis of the life insurance market and then continue with some fundamental and technical analysis of GNW. General Life Insurance Industry Trends Life insurance is not the only source of revenue for Genworth Financial, Inc., but is one of its main lines of business in and outside of the U.S. Taking a look at the trend of life insurance may also help identify the trend for another branch of their business, long-term care insurance. According to the LIMRA Insurance Barometer report for 2022, only 53% of men and 46% of women have life insurance. In my opinion, that means there is a large market out there still uncovered for providers of life insurance. Having said that, the question to ask is how many people feel they should be getting life insurance. I didn't know the direct answer to that question, but I did find clues: Over 100 million Americans do not have life insurance. 44% of women and 38% of men say they need, or need more, life insurance. 36% of uninsured women say they plan to buy life insurance for the next year. Data for the number of men that plan to buy life insurance over the next year was not included in the article mentioned above. That percentage could be lower than the one for women, as a smaller percentage of men believe they are underinsured. In either case, it looks like there are tens of millions of new potential life insurance customers for the industry to tap. Recent events like the COVID pandemic, which has created a lot of disruption in the lives of many, may have also awakened the need for more security. Genworth Financial Annual Report (Genworth Financial) The above table is from Genworth Financial's latest annual report, and we can see that life insurance is not the primary source of income. However, I see long-term care insurance as a similar product with similar potential in the marketplace. Mortgage Insurance Market Trend The mortgage insurance business is conducted through its subsidiary, Enact Holdings, Inc. (ACT). This area of their business may be of concern as we enter what may be the restrictive leg of the economic cycle. Home sales have been decreasing since the beginning of 2022 and look to fall further still. Monthly Home Sales (Trading Economics) Clearly, the lower the number of houses that change hands, presumably the smaller the number of mortgages written. And, therefore, the lower the demand for mortgage insurance. Yet, the recession we experienced in 2020 saw a 53% jump in mortgage insurance compared to 2019. This might be explained by the fact that usually lenders ask for mortgage insurance when the home buyer is not making a down payment or doesn't reach a minimum threshold. In times of mild recessions, many home buyers are likely to prefer keeping their savings and paying for mortgage insurance. This might explain the sharp increase in mortgage insurance sales despite the gloomy economic outlook in 2020. In my opinion, small or shallow recessions are not detrimental to mortgage insurance underwriters for this reason. What can be devastating is a full-blown depression where people start defaulting on their mortgages and insurance companies are obligated to cover the costs. However, it doesn't seem to me that we are in a housing bubble. Despite the waning housing data coming from most angles, we are nowhere near a comparison to 2008. Fundamental Analysis of Genworth Financial The fundamentals I typically look at to gauge the solidity and growth of a company are in the table below. The liabilities to assets ratio looks high in absolute terms. But in relative terms, when comparing to 3 of Genworth Financial's competitors, we see that the company has a slightly lower ratio. Company Liabilities to Assets Ratio Jackson Financial Inc. (JXN) 0.969 American Equity Investment Life (AEL) 0.954 National Western Life Group (NWLI) 0.951 I consider the most important factor when analyzing liabilities to assets the comparison to competitors within the same sector. So, I see this ratio for GWN as healthier than average. Looking at earnings, EBITA has risen from $438 million in 2018 to $1.093 billion TTM. Although the latest data for EBITA shows a decline, overall, the trend is still positive. Seeking Alpha Free cash flow showed a sharp decline in 2021, and that may have created some concern if the trend continued. However, the TTM for free cash flow shows a sharp rise, and it would seem GWN has put its house in order again. EPS has been on the increase since 2018, rising from $0.03 to $0.95. Again, in line with a lower EBITA from 2021, the TTM for EPS is lower than in 2021. However, the trend remains positive. Altogether, I see a positive trend in these numbers and the liabilities to assets ratio, which is still under control. SA Quant Performance The Quant Performance rating for Genworth Financial is a hold, with a score of 3.49 out of 5. However, I also see that of the 5-factor grades used to determine the rating, 3 have improved over the past 3 months while 2 have declined. Of the five factors, the one where GNW fails is growth with a flat D+. This factor carries a lot of weight on the Quant system, and a D+ in Growth disqualifies a stock for any grade higher than neutral, as explained in the Quant System FAQs. However, in the growth factor breakdown, we can see that there are two positive elements, EBITDA and free cash flow. My take is that profitability is improving as shown by EBITDA and EPS, and the trend looks set to continue. Technical Analysis for Genworth Financial My technical point of view is probably what makes me the most bullish about this stock. Looking at the monthly chart, we see that the price of Genworth Financial stock has been trading in a narrow range since October 2015. TradingView The sideways trading looks like it may be a floor for FWN stock price. Although the stock has been trading below the Ichimoku cloud, a clear bear trend, since 2015, that trend may have just been broken. Price action has moved above the Ichimoku cloud for the first time in 7 years. However, for the Ichimoku system to indicate a bull trend, other parts of the system must line up also. Namely, the lagging line (green line) is still in the cloud and must clear the cloud to confirm a bull market. Also, the forward part of the cloud must widen and turn green. Right now, it's very thin, typical of sideways trading markets. So, it may take a few months before we get confirmation and in that time any retracement in price shouldn't fall below the Ichimoku cloud. Short-Term Technical Point of View Looking at the Weekly chart, we also see a bullish environment. The Ichimoku system is entirely bullish. All the parts of the system are indicating a bullish market. We can also see how, in recent weeks, price has risen above a key resistance (blue horizontal line).

Seeking Alpha • Oct 18

Genworth Financial: Relative Strength Through Year-End

Summary Genworth Financial has been relatively resilient in an otherwise abysmal equity market, up 5% YTD. Several factors will decide if Genworth Financial's momentum lasts for the remainder of the year. This article discusses those factors and suggests topics investors should be looking for in Genworth's Q3 earnings report, set for November 1. Genworth remains a Buy with a price target of $5.20/sh. Genworth Financial, Inc. (GNW) has been relatively resilient in an otherwise abysmal equity market. The stock is up over 5% YTD compared to down 23% for the S&P500: Data by YCharts Whether Genworth's strength continues depends on several factors expected to unfold through the remainder of '22 and '23. Below is a summary of items investors should be looking for in the company's Q3 earnings on November 1st. Enact dividends Probably the most important item on the agenda is Enact Holdings, Inc.'s (ACT) performance and the likelihood of future dividends. At the moment, Genworth primarily relies on dividends from its ~81.6% equity stake in Enact to service debt, fund growth initiatives, and return cash to shareholders (Genworth Holding is also receiving capital via cash tax payments, however, those are expected to run out in '23). It is imperative dividends from Enact continue to flow until Genworth develops other cash flow streams. Despite the recent slowdown in mortgage originations, it is anticipated that Enact will continue to deliver on its regular quarterly dividend as well as the previously guided special dividend sometime in Q4. Although it is not expected, it would not be surprising considering the challenging macro-environment if management reduces the special dividend from the ~$200m discussed in Enact's Q2'22 earnings call. Share repurchase program With all '24 senior notes retired, Genworth can turn the company's free cash towards its $350m share repurchase plan. Announced in May, Genworth has purchased at least $30m worth of shares under the authorization, leaving ~$320 untapped. It is, however, unclear whether the company will have enough cash available at the holding company through year-end to exhaust the authorization while maintaining a 2x interest cash buffer on the balance sheet. Therefore, this is something to monitor closely. The share buyback program should benefit long-term investors by reducing the oversupply of Genworth's shares in the market. As of July 27th, there were ~503.7m Genworth S/O. The excessive amount of shares in the market along with Genworth's penny stock status has made it a haven for speculators and day traders. Presently, over 22% of Genworth's shares are held by retail investors (Public and Other): Seeking Alpha - GNW Conversely, only ~76% of Genworth shares are controlled by institutions compared to ~93% among peers: Seeking Alpha - GNW - Peers (Customized) As the company buys back shares in the market, it is anticipated that not only will long-term investors benefit from a rising share price, but also from reduced volatility. MYRAP Progress on Genworth's Multi-Year Rate Action Plan is something to keep a close eye on in the coming quarters. This is because, while the company and market assign nil value to the life business, as management continues to narrow the deficit between LTC premium and future liabilities, residual value could become realizable. As of June 30, the company has achieved $20.7b in rate increases or benefit reductions towards its $28.7b goal. Through 1H'22 alone, Genworth received $1.1b in approvals on a net present value basis. In Q3, investors should expect to see a positive impact from the PCS I and PCS II legal settlements, in addition to incremental premium increases allowed by state regulators. Moreover, starting in '23, Genworth will likely (at least temporarily) experience an acceleration towards reaching its breakeven goal under MYRAP as the company implements the Choice II legal settlement affecting over $1b of annual premiums (Choice II is Genworth's largest legacy LTC block). However, keep in mind the goal is subject to change as it is based on current assumptions that may differ in the future. Global Care Solutions Long-term investors stand to benefit tremendously if Genworth is successful in standing up its growth initiatives under the umbrella of Global Care Solutions ("GCS"). Presently, GCS consists of CareScout - Genworth's services & advisory business. There is also discussion of launching new LTC products through GCS, but those plans appear to have been postponed due to poor economics. At this point, little has been disclosed about CareScout's offerings or pricing, although the company's website states that its first product will be available sometime in 2023. Genworth recently announced the addition of Timothy Peck, a Harvard-educated medical doctor and entrepreneur, to head up GCS. Investors should expect to receive more details about the initiative in the Q3 report, but at this point, it is unlikely GCS will have a material impact on Genworth's stock. Genworth's investment portfolio As of June 30, Genworth had $63.2b in cash and investments in its portfolio: GNW 2Q'22 10-Q Between December 31, 2021 and June 30, the carrying value of Genworth's investment portfolio declined by $10.7b due, in part, to falling fixed securities prices. This trend is expected to continue through 2H. However, portfolio yields should fare better in 2H, with the cost of borrowing rising as the Fed continues to fight inflation with rate increases. Genworth reported a 4.8% investment yield in Q2 through 1H'22 compared to 5.0% in the same year-ago period: GNW 2Q'22 10-Q

Seeking Alpha • Sep 25

Genworth Financial: Strong Balance Sheet Offers Opportunities

Summary Genworth holding company has improved its balance sheet. Recent upgrades from ratings agencies. Opportunity with LIBOR plus junior notes.

Seeking Alpha • Aug 18

Genworth Financial's L&H Insurance Business Is Valued At Less Than Zero Despite Long-Term Solvency

Genworth Financial is quite a complicated story, where they have a mortgage insurance business, Enact, and a life & health insurance business that is not well-liked by markets. They did a minority IPO of Enact which values Genworth's residual shareholding at more than its market cap. Moreover, Genworth has substantial non-operating loss tax assets that create even more margin of safety and together with Enact value Genworth's residual life insurance business at a negative value. The L&H business is not great, as old blocks of business in long-term care were underwritten with uneconomical terms, and those rates are having to be increased through onerous processes involving state regulators. They have achieved substantially on these actuarially justified rate increases which benefit everyone, and with what has already been achieved the life insurance business should have a positive value. Genworth Financial (GNW) is a company that again provides an incredible margin of safety. It is an insurer of both mortgages and provides long-term care and life insurance policies. The company trades at a highly compressed valuation, and it is because its long-term care insurance business issued policies at very uneconomical rates for many years, which has created a substantial policy liability for the company. While it is true that this business isn't great, with clear anchors of value for the other parts of the business including the mortgage insurance business which has gone through a minority IPO (trading also as Enact Holdings (ACT) on the NASDAQ) and the substantial non-operating loss tax assets on the books, we see that on a sum-of-the-parts basis the health and life insurance part of Genworth's business has been given a negative value. Since investments still cover liabilities for the life and health insurance business, and we know this from being able to deconsolidate the separately trading Enact Holdings from the books, that negative value makes no sense. This is essentially a no-brainer buy. Sum of the Parts The Genworth Financial thesis is ultimately a sum-of-the-parts logic that can be easily followed. There are three elements to the business. The mortgage insurance business, which went through a minority IPO meaning Genworth still owns 81% of the shares (and therefore their results are still consolidated into Genworth's), the tax assets that arise from a tax sharing agreement among the constituent subsidiaries of Genworth's business and can now be realized thanks to their profitability, and finally the wart on the company's face which is the life and health insurance business. Life Insurance Segment The life insurance segment as a whole isn't such a problem, the issue is the long-term care business. It is currently very profitable, but this is very temporary. L&H Business (Q2 2022 Pres) As the years come, its covered groups are going to be exactly the age in which they will be making claims for the benefits insured by Genworth for their long-term care. As the name suggests, these benefits will be paid out for a while, and this nearing obligation is bloating the 'future policy and benefits' line in the balance sheet. Q2 Balance Sheet GNW (sec.gov) For some FIG review, that line in the balance sheet is the difference between the NPV of the benefits to be paid out according to company models, using things like morbidity and mortality assumptions and the ages of the insured pool, and the NPV of the net premiums which just means the part of annual premiums meant to cover claims, and are not for creating incremental economic return. Naturally, the aim of the insurance company is to gain premiums in excess of this net figure, as that is where the economic earnings come from. As you can see from the more granular data provided by GNW regarding the LTC segment, the bulge in their covered groups is just now beginning to see incremental benefit from their coverage and are still quite young. It'll be a decade before the herd begins to meaningfully thin on account of regular age-related mortality. Pain is coming for this segment. LTC Policyholders (Q2 2022 GNW Pres) How could this have happened? Essentially actuarial failure meant they mispriced these policies. Because it puts this obligation pressure on GNW, the company has been able to work with state regulators to change run-rate premiums from these policies in order to better shore up the GNW position. Because it is actuarially justified and is basically the correction of a 'mistake', they have been able to implement about $20 billion worth of rate changes on a discounted basis, and there are probably more coming although the process is onerous and multi-lateral. The regulators benefit from improving an insurer's solvency, and the mistakes were actuarial and shouldn't have happened in the first place. While customers suffer with premium hikes, they were benefiting from sub-market premiums for years. But it's not so important that further rate changes work out, because while the policies are still technically running uneconomically, the margin of diseconomy is already smaller than what you'd need to justify a negative value for this business segment, and you'll see in a moment why when we discuss Enact. Enact Holdings Enact is the second pillar of the thesis. It went through a minority IPO where GNW still owns 81% of the company, but the market has valued it at $4.39 billion. Therefore GNW's stake is already $3.5 billion. GNW's stock is worth $2.22 billion, so you can probably already see where this is going when we do the SotP later. But first, very briefly on their business. ACT insured mortgages and its market is that in order for banks to sell-off originated mortgages to GSEs, to free up capital for further lending, risk requirements need to be met. Where a mortgage might be too risky on a vanilla basis for GSEs to buy, a company like Genworth or Essent (ESNT) will insure just enough of the mortgage in order for the mortgage to qualify for sale off banks' balance sheets. Mortgages are too risky when essentially the LTV ratios are too high, usually because of low down-payment. With Millennials being the next generation of homebuyers, and with the secular trends for housing in the US being rather good, more of these mortgages are going to be needed to house the next generation of newly forming families. It's not a bad business, and WFH is another tailwind that is requiring more square footage per household, stealing area from offices and requiring larger total mortgages. In any case, because Enact is fully consolidated as per consolidation accounting, we can look at its balance sheet and deconsolidate it from Genworth's to get an idea of what the balance sheet looks like for the residual L&H business so get an idea of how problematic its balance sheet actually is. Enact BS (sec.gov) Enact has about $5.5 billion in assets to cover essentially $1.2 billion in current claims associated with mortgage defaults. While rate increases could mean more defaults, nothing is signaling higher default rates yet, so the net coverage of claims is about $4.3 billion from Enact. Going back to the GNW balance sheet, they have about $80 billion in investments and reinsurance of liabilities to cover about $75 billion in gross claims. Subtracting the assets from Enact of $4.3 billion puts them at actually a small surplus of $780 million. The claims here are coming from both future policy obligations, current reserves, long-term borrowings and also separate accounts liabilities and policyholder account balances (accounts held by essentially investors in GNW annuity and other cash generating securitised products, because remember fees and commissions earned on those sorts of things are a traditional way for insurance companies to make money without creating claim liabilities, the risk of those products are on the owners). That surplus can easily be increased by new rate action or just new properly priced business in L&H or elsewhere that can be built over the next several years without too much urgent pressure creating incremental spread between NPV of premiums and claims. They'll have time to improve their book as claims will come out relatively gradually (although they'll necessarily speed up as older people start claiming for LTC). The fact that the assets cover the liabilities even if only slightly is a great start for the SotP and for the operational margin of safety for the company. Tax Assets We already see that Enact Holdings' shares that GNW owns are more than GNW's market cap by quite a lot. But there's more: substantial NOLs that are tax assets for the company. These come from some tax sharing agreements between company subsidiaries, but ultimately they're on the balance sheet in black and white and are of serious value to the business. In 2021 they realized $119 million in NOLs to offset taxes. There are $960 million in NOL assets of the latest balance sheet date. While that book value is a decent way to value them, let's consider discounting effects because those NOLs only come into action as profits are realized. Assuming around $80 million in realized assets (lower than the current $119 million on the basis of some headwinds from the poorly priced LTC policies) create cash flow for the next 5 years, we get a $406 million value when discounting at a pretty reasonable 7% rate. Discount rates are bit arbitrary, but this assumes CAPM assumptions for cost of equity. SotP Now we can build the SotP valuation. Valuation (VTS) Because we used long-term borrowings, cash and other liabilities and assets in the surplus calculation for the LTC business standalone, after deconsolidating Enact's balance sheet, we have all we need for the valuation treating Enact like a non-operating asset, and of course paying attention to tax assets. The market implies a negative value for the L&H business which includes substantially the LTC business. Just giving that business a 0 valuation rather than a very negative one means a lot of upside.

Seeking Alpha • Aug 01

Genworth Financial Non-GAAP EPS of $0.34 beats by $0.04, revenue of $1.88B misses by $100M

Genworth Financial press release (NYSE:GNW): Q2 Non-GAAP EPS of $0.34 beats by $0.04. Revenue of $1.88B (-7.8% Y/Y) misses by $100M. Received first quarterly dividend from Enact of $19 million. U.S. life insurance companies’ risk-based capital ratio estimated at 290 percent Retired $48 million of debt, bringing holding company total debt to $1,052 million; cash and liquid assets of $228 million Executed $30 million in share repurchases through July 2022.

Seeking Alpha • May 28

Genworth Financial: Fueling Value Creation

Genworth has started returning capital to shareholders in the form of a $350m share repurchase plan. The return is just one manifestation of the solid progress Genworth has made over the last several years to secure the future for its shareholders. As time marches on, favorable progress across the business is expected to continue for Genworth. The company will, however, continue to face its share of uncertainty. Despite the risks, Genworth is currently on very solid footing, and should remain that way for the foreseeable future. Therefore, Genworth is a Buy with an increased Price Target of $5.10/sh.

Score flocon de neige
Évaluation	0/6
Croissance future	0/6
Performances passées	1/6
Santé financière	3/6
Dividendes	0/6

Historique des cours de bourse
Prix actuel de l'action	US$9.40
Plus haut sur 52 semaines	US$9.45
Plus bas sur 52 semaines	US$7.13
Bêta	0.87
Variation sur 1 mois	4.10%
Variation sur 3 mois	17.65%
Variation sur 1 an	20.36%
Variation sur 3 ans	89.90%
Variation sur 5 ans	137.97%
Évolution depuis l'introduction en bourse	-51.79%

	GNW	US Insurance	US Marché
7D	5.0%	1.9%	-2.7%
1Y	20.4%	-3.9%	18.6%

GNW volatility
GNW Average Weekly Movement	3.1%
Insurance Industry Average Movement	4.1%
Market Average Movement	7.2%
10% most volatile stocks in US Market	16.9%
10% least volatile stocks in US Market	3.1%

GNW statistiques fondamentales
Capitalisation boursière	US$3.56b
Bénéfices(TTM)	US$211.00m
Recettes(TTM)	US$7.29b

GNW compte de résultat (TTM)
Recettes	US$7.29b
Coût des recettes	US$6.77b
Marge brute	US$524.00m
Autres dépenses	US$313.00m
Les revenus	US$211.00m

Résultat par action (EPS)	0.55
Marge brute	7.19%
Marge bénéficiaire nette	2.89%
Ratio dettes/capitaux propres	23.4%

Données	Dernière mise à jour (heure UTC)
Analyse de l'entreprise	2026/06/25 11:34
Cours de l'action en fin de journée	2026/06/25 00:00
Les revenus	2026/03/31
Revenus annuels	2025/12/31

Paquet	Données	Cadre temporel	Exemple de source américaine ^*
Finances de l'entreprise	10 ans	Compte de résultat Tableau des flux de trésorerie Bilan	Formulaire 10-K de la SEC Formulaire 10-Q de la SEC
Estimations consensuelles des analystes	+3 ans	Prévisions financières Objectifs de prix des analystes	Rapports de recherche des analystes Blue Matrix
Prix du marché	30 ans	Cours des actions Dividendes, scissions et actions	Données de marché ICE Formulaire S-1 de la SEC
Propriété	10 ans	Actionnaires principaux Délits d'initiés	Formulaire 4 de la SEC Formulaire 13D de la SEC
Gestion	10 ans	L'équipe dirigeante Conseil d'administration	Formulaire 10-K de la SEC Formulaire SEC DEF 14A
Principaux développements	10 ans	Annonces de l'entreprise	Formulaire 8-K de la SEC

Analyste	Institution
Eric Berg	Barclays
Ryan Gilbert	BTIG
Paul Holden	CIBC Capital Markets

Genworth Financial (GNW) Aperçu de l'action

Récompenses

Analyse des risques

Genworth Financial, Inc. Concurrents

CNO Financial Group

F&G Annuities & Life

Lincoln National

Primerica

Historique des prix et performances

Nouvelles et mises à jour récentes

Genworth Financial Stock Sees Steady Revenue as Enact and CareScout Drive Growth and Buybacks

Genworth Financial (GNW) Stock Looks Rich After CareScout Launch And Enact Strength

Enact Holdings Continues To Be The Driver For Genworth Financial

Independent Director recently sold US$456k worth of stock

President notifies of intention to sell stock

Genworth Financial Reports Strong Cash Flow and Expands Share Buybacks in Q1 2026

Recent updates

Genworth Financial Stock Sees Steady Revenue as Enact and CareScout Drive Growth and Buybacks

Genworth Financial (GNW) Stock Looks Rich After CareScout Launch And Enact Strength

Enact Holdings Continues To Be The Driver For Genworth Financial

Independent Director recently sold US$456k worth of stock

President notifies of intention to sell stock

Genworth Financial Reports Strong Cash Flow and Expands Share Buybacks in Q1 2026

First quarter 2026 earnings released: EPS: US$0.12 (vs US$0.14 in 1Q 2025)

Genworth Financial, Inc. to Report Q1, 2026 Results on May 05, 2026

Genworth Financial, Inc., Annual General Meeting, May 20, 2026

Full year 2025 earnings released: EPS: US$0.54 (vs US$0.71 in FY 2024)

Genworth Financial, Inc. to Report Q4, 2025 Results on Feb 23, 2026

President recently sold US$346k worth of stock

President notifies of intention to sell stock

Executive VP & General Counsel recently sold US$340k worth of stock

Executive VP & General Counsel notifies of intention to sell stock

Third quarter 2025 earnings released: EPS: US$0.30 (vs US$0.20 in 3Q 2024)

Now 22% overvalued after recent price rise

Price target increased by 11% to US$10.00

Genworth Financial, Inc. to Report Q3, 2025 Results on Nov 05, 2025

Genworth Financial, Inc. (NYSE:GNW) announces an Equity Buyback for $350 million worth of its shares.

Now 20% overvalued after recent price rise

Insider recently sold US$750k worth of stock

Now 20% overvalued after recent price rise

Second quarter 2025 earnings released: EPS: US$0.14 (vs US$0.18 in 2Q 2024)

Genworth Financial, Inc. to Report Q2, 2025 Results on Jul 30, 2025

Genworth Financial, Inc.'s (NYSE:GNW) Price Is Right But Growth Is Lacking

Investor sentiment improves as stock rises 15%

Price target increased by 13% to US$9.00

First quarter 2025 earnings released: EPS: US$0.14 (vs US$0.32 in 1Q 2024)

Genworth Financial, Inc. to Report Q1, 2025 Results on Apr 30, 2025

Investor sentiment deteriorates as stock falls 16%

Genworth Appoints Morris Taylor as Senior Vice President and Chief Information Officer

Insufficient new directors

Genworth Financial, Inc., Annual General Meeting, May 22, 2025

Genworth Continues Gradual Progress, But Enact Is Under Pressure

Investors Don't See Light At End Of Genworth Financial, Inc.'s (NYSE:GNW) Tunnel

Full year 2024 earnings released: EPS: US$0.71 (vs US$0.16 in FY 2023)

Genworth Financial, Inc. to Report Q4, 2024 Results on Feb 18, 2025

Third quarter 2024 earnings released: EPS: US$0.20 (vs US$0.063 in 3Q 2023)

Genworth Financial, Inc. to Report Q3, 2024 Results on Nov 06, 2024

A Failed Merger May Have Been Just What Genworth Financial Needed For A Turnaround

Genworth Financial, Inc.'s (NYSE:GNW) Price Is Right But Growth Is Lacking

President recently sold US$1.0m worth of stock

President notifies of intention to sell stock

Second quarter 2024 earnings released: EPS: US$0.18 (vs US$0.28 in 2Q 2023)

Genworth Financial, Inc. to Report Q2, 2024 Results on Jul 31, 2024

President recently sold US$1.3m worth of stock

President notifies of intention to sell stock

Investors Aren't Buying Genworth Financial, Inc.'s (NYSE:GNW) Revenues

First quarter 2024 earnings released: EPS: US$0.32 (vs US$0.25 in 1Q 2023)

Genworth Financial, Inc., Annual General Meeting, May 23, 2024

Genworth Financial, Inc. to Report Q1, 2024 Results on May 01, 2024

Insufficient new directors

Full year 2023 earnings released: EPS: US$0.16 (vs US$1.21 in FY 2022)

Genworth Financial, Inc. to Report Q4, 2023 Results on Feb 21, 2024

Genworth Financial, Inc. Announces Principal Accounting Officer Changes

There Is A Reason Genworth Financial, Inc.'s (NYSE:GNW) Price Is Undemanding

Genworth Financial, Inc. Announces Executive Changes

President recently sold US$1.2m worth of stock

President notifies of intention to sell stock

Genworth's Sum Of The Parts May Be Greater Than The Whole

Third quarter 2023 earnings released: EPS: US$0.063 (vs US$0.20 in 3Q 2022)

Genworth Financial, Inc. to Report Q3, 2023 Results on Nov 08, 2023